Artemisinin Derivatives Market

Market Insights

The Artemisinin Derivatives market was valued at USD 655 million in 2020 and expected to grow at a CAGR of 6.05% during the forecast period from 2021 to 2027 to reach around USD 1,080 million in 2027.

Artemisinin derivatives are a group of active pharmaceutical ingredients which are used in the treatment of malaria. Artemisinin and its derivatives effectively fight against malarial and parasitic worm (helminth) infections. They have been proven to be the most effective and potential drugs to kill the parasites and their life cycle. Artemisinin is typically derived from the plant Artemisia annua and sweet wormwood. The global Artemisinin Derivatives market report offers detailed market insights on Artemisinin Derivatives at the global, regional, and country levels.

The key regions covered in the report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Major countries covered in the report are the U.S., Canada, Mexico, Brazil, Argentina, China, Japan, India, South Korea, Germany, UK, France, Italy, Spain, Russia, South Africa, Turkey, Israel, GCC countries, etc. The report provides the market size of Artemisinin Derivatives for historical periods, i.e., from 2015 to 2019, estimates for the current year, and forecasts for the period between 2021 to 2027. The market size of Artemisinin Derivatives is a further breakdown on regional and country levels.

Global Artemisinin Derivatives Market Share by Region, 2020

Based on its type, the global Artemisinin Derivatives market can be segmented into Dihydroartemisinin, Artemisunate, and Others. The Dihydroartemisinin segment has over 45% share of total revenue generated by Artemisinin Derivatives in 2020. Dihydroartemisinin is the active metabolite of all artemisinin compounds, including artemisinin, artesunate, artemether, etc. Each above segment and subsegment is then further bifurcated at the global, regional, and country levels. Finally, the market size for each segment and subsegment is given in terms of volume and value (USD Million) for historical, present and forecast years.

Global Artemisinin Derivatives Market by Application Insights

Based on its application, the global Artemisinin Derivatives market can be segmented into Malaria Treatment, Scientific Research, and Others. The Malaria Treatment segment dominated the global Artemisinin Derivatives demand in 2020 with over 60% share in total revenue generated by this industry. Each above segment and subsegment is then further bifurcated at global, regional, and country levels. Finally, the market size for each segment and subsegment is given in terms of volume and value (USD Million) for historical, present and forecast years.

Global Artemisinin Derivatives Market Share by Application, 2020

Apart from quantitative analysis, the global Artemisinin Derivatives market report offers key trends in the industry. The report covers all key market driving forecasts, restraints, and opportunities for future growth in this industry. The report helps its readers to identify the key growth pockets in the global Artemisinin Derivatives industry through market attractiveness analysis offered for each segment in this industry. Moreover, a detailed analysis of the Artemisinin Derivatives industry using porter’s five forces analysis helps the buyers of this report to have a bird’s eye view of various aspects of this industry. It details the bargaining power of buyers as well as suppliers, the situation of competitive rivalry, the threat of substitutes, and entry barriers for new entrants.

The global Artemisinin Derivatives market report also covers import and export analysis on a regional level. The global Artemisinin Derivatives market includes the most updated insights, including COVID 19 impact analysis. In addition, the report covers a comparative analysis of the global Artemisinin Derivatives market on the basis of pre and post-COVID 19 scenarios.

Apart from this, the report covers a dedicated section for the analysis of competition in the global Artemisinin Derivatives industry. The report offers detailed company market share analysis on a global level which helps to understand the competitive scenario in the Artemisinin Derivatives industry. In addition, a detailed company profile section offers detailed insights about leading players in the Artemisinin Derivatives market. The company profile of each leading player includes a company overview, detailed product portfolio, and financial details such as sales volume, revenue, gross margin, etc. for Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Ltd and others.

Global Artemisinin Derivatives Market, Company Share 2020

The global Artemisinin Derivatives market report also offers insights into manufacturing cost analysis. This section focused on the analysis of raw material cost, key suppliers of raw materials, labor cost, market concentration of raw materials, manufacturing cost proportion of Artemisinin Derivatives, etc. This report highlights the manufacturing expenses and the manufacturing process of Artemisinin Derivatives. In addition, the repot also helps to understand the marketing channels used by most Artemisinin Derivatives industry players.

Historical & Forecast Period

2015 to 2020 – Historical Years

2021 – Current Year

2021 – 2027 – Forecast Period

This study report represents analysis for each segment from 2015 to 2027, considering 2019 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2020 to 2027.

Market Segmentation

Global Artemisinin Derivatives Market by Type, 2015 – 2027

• Dihydroartemisinin
• Artesunate
• Others

Global Artemisinin Derivatives Market by Application, 2015 – 2027

• Malaria Treatment
• Scientific Research
• Others

Global Artemisinin Derivatives Market by Region, 2015 – 2027

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Global Artemisinin Derivatives Market: Key Players

• Sanofi
• KPC Pharmaceuticals
• Guangxi Xiancaotang Pharmaceutical
• Guilin Pharmaceutical
• Kerui Nanhai Pharmaceutical
• Shanghai Natural Bio-engineering Co
• Novant Bioresource
• Botanical Extracts EPZ Ltd
• Others

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better understanding of the overall Artemisinin Derivatives market. In addition, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary

2.1. Market Snapshot: Global Artemisinin Derivatives Market
2.2. Global Artemisinin Derivatives Market, by Product, 2019 (US$ Bn)
2.3. Global Artemisinin Derivatives Market, by Application, 2019 (US$ Bn)
2.4. Global Artemisinin Derivatives Market, by Technology, 2019 (US$ Bn)
2.5. Global Artemisinin Derivatives Market, by End-user, 2019 (US$ Bn)
2.6. Global Artemisinin Derivatives Market, by Geography, 2019 (US$ Bn)

3. Market Dynamics

3.1. Introduction
3.1.1. Global Artemisinin Derivatives Market Value, 2015-2027, (US$ Bn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2019
3.4. Market Positioning of Key Players, 2019
3.4.1. Major Strategies Adopted by Key Players

4. Global Artemisinin Derivatives Market, by Product, 2015-2027 (US$ Bn)

4.1. Overview
4.2. Dihydroartemisinin
4.3. Artemisunate
4.4. Others
5. Global Artemisinin Derivatives Market, by End-user, 2015-2027 (US$ Bn)
5.1. Overview
5.2. Malaria Treatment
5.3. Scientific Research
5.4. Others

6. North America Artemisinin Derivatives Market Analysis, 2015-2027 (US$ Bn)

6.1. Overview
6.1.1. North America Artemisinin Derivatives Market Value and Growth, 2015-2027, (US$ Bn)
6.2. North America Artemisinin Derivatives Market Value, By Product, 2015-2027 (US$ Bn)
6.2.1. Market Analysis
6.3. North America Artemisinin Derivatives Market Value, By End-user, 2015-2027 (US$ Bn)
6.3.1. Market Analysis
6.4. North America Artemisinin Derivatives Market Value, By Region/Country, 2015-2027 (US$ Bn)
6.4.1. Market Analysis
6.4.2. U.S.
6.4.3. Rest of North America

7. Europe Artemisinin Derivatives Market Analysis, 2015-2027 (US$ Bn)

7.1. Overview
7.1.1. Europe Artemisinin Derivatives Market Value and Growth, 2015-2027, (US$ Bn)
7.2. Europe Artemisinin Derivatives Market Value, By Product, 2015-2027 (US$ Bn
7.2.1. Market Analysis
7.3. Europe Artemisinin Derivatives Market Value, By End-user, 2015-2027 (US$ Bn)
7.3.1. Market Analysis
7.4. Europe Artemisinin Derivatives Market Value, By Region/Country, 2015-2027 (US$ Bn)
7.4.1. Market Analysis
7.4.2. U.K.
7.4.3. Germany
7.4.4. France
7.4.5. Rest of Europe

8. Asia Pacific Artemisinin Derivatives Market Analysis, 2015-2027 (US$ Bn)

8.1. Overview
8.1.1. Asia Pacific Artemisinin Derivatives Market Value and Growth, 2015-2027, (US$ Bn)
8.2. Asia Pacific Artemisinin Derivatives Market Value, By Product, 2015-2027 (US$ Bn)
8.2.1. Market Analysis
8.3. Asia Pacific Artemisinin Derivatives Market Value, By End-user, 2015-2027 (US$ Bn)
8.3.1. Market Analysis
8.4. Asia Pacific Artemisinin Derivatives Market Value, By Region/Country, 2015-2027 (US$ Bn)
8.4.1. Market Analysis
8.4.2. Japan
8.4.3. China
8.4.4. India
8.4.5. Rest of Asia Pacific

9. Rest of the World Artemisinin Derivatives Market Analysis, 2015-2027 (US$ Bn)

9.1. Overview
9.1.1. Rest of the World Artemisinin Derivatives Market Value and Growth, 2015-2027, (US$ Bn)
9.2. Rest of the World Artemisinin Derivatives Market Value, By Product, 2015-2027 (US$ Bn)
9.2.1. Market Analysis
9.3. Rest of World Artemisinin Derivatives Market Value, By End-user, 2015-2027 (US$ Bn)
9.3.1. Market Analysis
9.4. Rest of the World Artemisinin Derivatives Market Value, By Region, 2015-2027 (US$ Bn)
9.4.1. Market Analysis
9.4.2. Middle East & Africa
9.4.3. Latin America

10. Company Profiles

10.1. Sanofi
10.2. KPC Pharmaceuticals
10.3. Guangxi Xiancaotang Pharmaceutical
10.4. Guilin Pharmaceutical
10.5. Kerui Nanhai Pharmaceutical
10.6. Shanghai Natural Bio-engineering Co
10.7. Novanat Bioresource
10.8. Botanical Extracts EPZ Ltd
10.9. Company 10
10.10. Company 11
10.11. Company 12
10.12. Company 13

List of Figures

FIG. 1 Global Beauty Devices (Artemisinin Derivatives) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Artemisinin Derivatives Market Segmentation
FIG. 4 Global Artemisinin Derivatives Market, by Product, 2019 (US$ Bn)
FIG. 5 Global Artemisinin Derivatives Market, by End-user, 2019 (US$ Bn)
FIG. 6 Global Artemisinin Derivatives Market, by Geography, 2019 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Geography, 2019
FIG. 8 Global Market Positioning of Key Artemisinin Derivatives Market Manufacturers, 2019
FIG. 9 Global Artemisinin Derivatives Market Value Contribution, By Product, 2019 & 2027 (Value %)
FIG. 10 Global Artemisinin Derivatives Market, by Dihydroartemisinin, Value, 2015-2027 (US$ Bn)
FIG. 11 Global Artemisinin Derivatives Market, by Artemisunate, Value, 2015-2027 (US$ Bn)
FIG. 12 Global Artemisinin Derivatives Market, by Product 3, Value, 2015-2027 (US$ Bn)
FIG. 13 Global Artemisinin Derivatives Market, by Product 4, Value, 2015-2027 (US$ Bn)
FIG. 14 Global Artemisinin Derivatives Market, by Product 5, Value, 2015-2027 (US$ Bn)
FIG. 15 Global Artemisinin Derivatives Market, by Others, Value, 2015-2027 (US$ Bn)
FIG. 16 Global Artemisinin Derivatives Market Value Contribution, By End-user, 2019 & 2027 (Value %)
FIG. 17 Global Artemisinin Derivatives Market, by Malaria Treatment, Value, 2015-2027 (US$ Bn)
FIG. 18 Global Artemisinin Derivatives Market, by Scientific Research, Value, 2015-2027 (US$ Bn)
FIG. 19 Global Artemisinin Derivatives Market, by End-user 3, Value, 2015-2027 (US$ Bn)
FIG. 20 Global Artemisinin Derivatives Market, by End-user 4, Value, 2015-2027 (US$ Bn)
FIG. 21 Global Artemisinin Derivatives Market, by End-user 5, Value, 2015-2027 (US$ Bn)
FIG. 22 Global Artemisinin Derivatives Market, by Others, Value, 2015-2027 (US$ Bn)
FIG. 23 U.S. Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 24 Rest of North America Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 25 U.K. Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 26 Germany Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 27 France Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 28 Rest of Europe Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 29 Japan Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 30 China Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 31 India Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 32 Rest of Asia Pacific Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 33 Middle East & Africa Artemisinin Derivatives Market, 2015-2027 (US$ Bn)
FIG. 34 Latin America Artemisinin Derivatives Market, 2015-2027 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Beauty Devices (Artemisinin Derivatives) Market
TABLE 2 Global Artemisinin Derivatives Market, by Product, 2015-2027 (US$ Bn)
TABLE 3 Global Artemisinin Derivatives Market, by Application, 2015-2027 (US$ Bn)
TABLE 4 Global Artemisinin Derivatives Market, by Technology, 2015-2027 (US$ Bn)
TABLE 5 Global Artemisinin Derivatives Market, by End-user, 2015-2027 (US$ Bn)
TABLE 6 Global Artemisinin Derivatives Market, by Geography, 2015-2027 (US$ Bn)
TABLE 7 North America Artemisinin Derivatives Market, by Product, 2015-2027 (US$ Bn)
TABLE 8 North America Artemisinin Derivatives Market, by End-user, 2015-2027 (US$ Bn)
TABLE 9 North America Artemisinin Derivatives Market, by Country, 2015-2027 (US$ Bn)
TABLE 10 Europe Artemisinin Derivatives Market, by Product, 2015-2027 (US$ Bn)
TABLE 11 Europe Artemisinin Derivatives Market, by End-user, 2015-2027 (US$ Bn)
TABLE 12 Europe Artemisinin Derivatives Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 13 Asia Pacific Artemisinin Derivatives Market, by Product, 2015-2027 (US$ Bn)
TABLE 14 Asia Pacific Artemisinin Derivatives Market, by End-user, 2015-2027 (US$ Bn)
TABLE 15 Asia Pacific Artemisinin Derivatives Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 16 RoW Artemisinin Derivatives Market, by Product, 2015-2027 (US$ Bn)
TABLE 17 RoW Artemisinin Derivatives Market, by End-user, 2015-2027 (US$ Bn)
TABLE 18 RoW Artemisinin Derivatives Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 19 Company 01: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 20 Company 2: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Company 3: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Company 4.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Company 5: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Company 6: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 25 Company 7: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 26 Company 8: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 27 Company 9: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 28 Company 10: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 29 Company 11: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 30 Company 12: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 31 Company 13: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments